EFFICACY AND SAFETY OF LAROTRECTINIB IN PAEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER: AN EXTENDED FOLLOW-UP

被引：0

作者：

Zwaan, C. Michel ^{[1
]}

Van Tilburg, Cornelis ^{[2
,3
]}

Doz, Francois ^{[4
,5
]}

Albert, Catherine ^{[6
]}

Blattmann, Claudia ^{[7
]}

Geoerger, Birgit ^{[8
]}

Dubois, Steven ^{[9
]}

Federman, Noah ^{[10
]}

Mascarenhas, Leo ^{[11
]}

Nagasubramanian, Rama ^{[12
]}

Pappo, Alberto ^{[13
]}

Watt, Tanya ^{[14
]}

Norenberg, Ricarda ^{[15
]}

Dima, Laura ^{[16
]}

De la Cuesta, Esther ^{[17
]}

Laetsch, Theodore ^{[18
]}

Xu, Ruihua ^{[19
]}

机构：

[1] Princess Maxima Ctr Pediat Oncol, Stem Cell Transplantat Unit, Utrecht, Netherlands

[2] ErasmusMC Sophias Childrens Hosp, Pediat Oncol, Rotterdam, Netherlands

[3] Heidelberg Univ Hosp, German Canc Res Ctr DKFZ, Hopp Childrens Canc Ctr Heidelberg kitz, Heidelberg, Germany

[4] SIREDO Oncol Ctr Care, Inst Curie, Innovat & Res Children & AYA Canc, Paris, France

[5] Univ Paris Cite, Pediat, Paris, France

[6] Univ Washington Sch Med, Seattle Childrens Hosp, Dept Hematol Oncol, Seattle, WA USA

[7] Olgahospital, Dept Haematol & Oncol, Stuttgart, Germany

[8] Univ Paris Saclay, Gustave Roussy Canc Ctr, Dept Pediat & Adolescent Oncol, Villejuif, France

[9] Dana Farber Hosp, Childrens Canc & Blood Disorders Ctr, Boston, MA USA

[10] David Geffen Sch Med, UCLA Jonsson Comprehensive Canc Ctr, Pediat Hematol Oncol, Los Angeles, CA USA

[11] Univ Southern Calif Keck Sch Med, Childrens Hosp Angeles, Canc & Blood Dis Inst, Dept Hematol Oncol, Los Angeles, CA USA

[12] Childrens Hosp, Dept Hematol Oncol, Orlando, FL USA

[13] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA

[14] Univ Texas, SouthWestern Med Ctr, Dept Pediat, Austin, TX USA

[15] Chrestos Concept GmbH Co KG, Essen, Germany

[16] Bayer HealthCare SAS, Med Affairs, Garenne Colombes, France

[17] Bayer HealthCare Pharmaceut Inc, Oncol, Whippany, NJ USA

[18] Univ Pennsylvania, Childrens Hosp Philadelphia, Dev Therapeut Program, Philadelphia, PA USA

[19] Sun Yat sen Univ Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP379

引用

页码：S324 / S325

页数：2

共 50 条

[1] LONG-TERM FOLLOW-UP OF THE EFFICACY AND SAFETY OF LAROTRECTINIB IN PAEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER
Federman, Noah
Van Tilburg, Cornelis
Dierselhuis, Miranda
Albert, Catherine
Geoerger, Birgit
Dubois, Steven
Mascarenhas, Leo
Nagasubramanian, Ramamoorthy
Pappo, Alberto
Watt, Tanya
Bernard-Gauthier, Vadim
Norenberg, Ricarda
De la Cuesta, Esther
Doz, Francois
Zhang, Yizhuo
PEDIATRIC BLOOD & CANCER, 2023, 70
[2] Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up
McDermott, R. S.
van Tilburg, C.
Lin, J. J.
Kummar, S.
Tan, D. S. W.
Albert, C. M.
Berlin, J. D.
Lassen, U. N.
Doz, F.
Geoerger, B.
Mascarenhas, L.
Federman, N.
Norenberg, R.
Dima, L.
Mussi, C.
De La Cuesta, E. A.
Laetsch, T.
Hong, D. S.
Drilon, A. E.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S751 - S752
[3] Extended Follow-up of Efficacy and Safety of Larotrectinib in Patients With TRK Fusion Lung Cancer
Moreno, V.
Lin, J. J.
Tan, D. S. W.
Kummar, S.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Patel, J. D.
Rosen, L.
Solomon, B.
Yachnin, J.
Norenberg, R.
Fellous, M.
Mussi, C. E.
Shen, L.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S473 - S474
[4] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Drilon, A.
Moreno, V.
Patel, J.
Lassen, U. N.
Solomon, B.
Rosen, L.
Leyvraz, S.
Tan, D. S. W.
Reeves, J. A.
Dima, L.
Brega, N.
Kummar, S.
Farago, A. F.
ANNALS OF ONCOLOGY, 2020, 31 : S834 - S834
[5] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
Tan, D.
Farago, A.
Kummar, S.
Moreno, V.
Patel, J.
Lassen, U.
Solomon, B.
Rosen, L.
Leyvraz, S.
Reeves, J.
Brega, N.
Dima, L.
Childs, B.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S176 - S176
[6] Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer
Brose, M. S.
Shen, L.
Tan, D. S. W.
Kummar, S.
Lin, J. J.
McDermott, R.
Berlin, J.
Tahara, M.
Lassen, U. N.
Leyvraz, S.
Patel, J. D.
Norenberg, R.
Dima, L.
Brega, N.
Hong, D. S.
Drilon, A.
ANNALS OF ONCOLOGY, 2021, 32 : S600 - S601
[7] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
Drilon, A.
Moreno, V.
Patel, J.
Lassen, U.
Solomon, B.
Rosen, L.
Leyvraz, S.
Tan, D. S. W.
Reeves, J. A.
Dima, L.
Brega, N.
Kummar, S.
Farago, A. F.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S30 - S31
[8] Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer
Drilon, A.
Shen, L.
van Tilburg, C.
Doz, F.
Tan, D. S. W.
Lin, J. J.
Kummar, S.
Lassen, U. N.
McDermott, R. S.
Dierselhuis, M. P.
Albert, C. M.
Nagasubramanian, R.
Watt, T.
Patil, T.
Burcoveanu, D-I.
Norenberg, R.
Brega, N.
Laetsch, T. W.
Xu, R-H.
Hong, D. S.
ANNALS OF ONCOLOGY, 2023, 34 : S470 - S470
[9] Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer.
Drilon, Alexander E.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Patel, Jyoti D.
Lassen, Ulrik Niels
Leyvraz, Serge
Moreno, Victor
Rosen, Lee S.
Solomon, Benjamin Maurice
Yachnin, Jeffrey
Liu, Yongmei
Dai, Ming-Shen
Norenberg, Ricarda
Fellous, Marc Mardoche
Mussi, Chiara Erminia
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[10] Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer
Drilon, A.
Lin, J.
Lassen, U.
Leyvraz, S.
Liu, Y.
Patel, J.
Rosen, L.
Solomon, B.
Norenberg, R.
Dima, L.
Brega, N.
Shen, L.
Moreno, V.
Kummar, S.
Tan, D.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1125 - S1126

← 1 2 3 4 5 →